Clinical Outcomes in Patients with Non-Small-Cell Lung Cancer (NSCLC) Harboring Rare Epidermal Growth Factor Receptor (EGFR) Mutations

被引：0
|
作者：
Domingues, Pedro M. [1 ]
Montella, Tatiane [1 ]
Zukin, Mauro [1 ]
Baldotto, Clarissa [1 ]
Ferreira, Carlos [1 ]
机构：
[1] Brazilian Natl Canc Inst, Dept Thorac Oncol, Rio De Janeiro, Brazil
来源：
JOURNAL OF THORACIC ONCOLOGY | 2015年 / 10卷 / 09期
关键词：
EGFR TKI; EGFR rare mutations; advanced NSCLC;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ORAL17.05
引用
收藏
页码：S206 / S207
页数：2
相关论文
共 50 条
  • [1] CLINICAL OUTCOMES IN ERLOTINIB-TREATED PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG CANCER (NSCLC) HARBORING VERY RARE EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) MUTATIONS
    Domingues, Pedro Masson
    Montella, Tatiane
    Baldotto, Clarissa Serodio
    Siqueira, Mariana
    Zukin, Mauro
    Ferreira, Carlos Gil
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (09) : S169 - S169
  • [2] Clinical Features of Patients with Non-Small Cell Lung Cancer (NSCLC) Harboring Epidermal Growth Factor Receptor (EGFR) Mutations in Brunei
    Lu, S. K.
    Leong, C. H.
    Diah, S. Binti Hj Mohd
    Patnaik, R.
    Sukumaran, B.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2207 - S2207
  • [3] Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small-Cell Lung Cancer (NSCLC)
    O'Leary, Connor
    Gasper, Harry
    Sahin, Katherine B.
    Tang, Ming
    Kulasinghe, Arutha
    Adams, Mark N.
    Richard, Derek J.
    O'Byrne, Ken J.
    [J]. PHARMACEUTICALS, 2020, 13 (10) : 1 - 16
  • [4] Clinical Impact of Rare and Compound Mutations of Epidermal Growth Factor Receptor in Patients With Non-Small-Cell Lung Cancer
    Martin, Juliane
    Lehmann, Annika
    Klauschen, Frederick
    Hummel, Michael
    Lenze, Dido
    Grohe, Christian
    Tessmer, Ante
    Gottschalk, Joachim
    Schmidt, Berndt
    Pau, Hans-Wilhelm
    Witt, Christian
    Moegling, Stefan
    Kromminga, Robert
    Joehrens, Korinna
    [J]. CLINICAL LUNG CANCER, 2019, 20 (05) : 350 - +
  • [5] Multicenter prospective study of erlotinib in advanced non-small-cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) mutations
    Cardenal, Felipe
    Moran, Teresa
    Queralt, Cristina
    Porta, Ruth
    Camps, Carlos
    Majem, Margarita
    Lopez-Vivanco, Guillermo
    Isla, Dolores
    Provencio, Mariano
    Sanchez, Jose Javier
    Taron, Miquel
    Rosell, Rafael
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S324 - S325
  • [6] Rare epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer
    Harrison, Peter T.
    Vyse, Simon
    Huang, Paul H.
    [J]. SEMINARS IN CANCER BIOLOGY, 2020, 61 : 167 - 179
  • [7] Mutations of the epidermal growth factor receptor (EGFR) gene in non-small cell lung cancer (NSCLC).
    Sonobe, M
    Katakura, H
    Adachi, T
    Wada, H
    Tanaka, F
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 637S - 637S
  • [8] Clinical Characteristics and Survival Outcomes for Non-Small-Cell Lung Cancer Patients with Epidermal Growth Factor Receptor Double Mutations
    Peng, Min
    Weng, Yi Ming
    Liu, Hua Li
    Yang, Gui Fang
    Yao, Yi
    Han, Guang
    Song, Qi Bin
    [J]. BIOMED RESEARCH INTERNATIONAL, 2018, 2018
  • [9] MUTATIONS IN THE EPIDERMAL GROWTH FACTOR RECEPTOR GENE IN NON-SMALL-CELL LUNG CANCER PATIENTS AND EGFR SERUM LEVELS
    Romero-Ventosa, E. Y.
    Rodriguez Rodriguez, M.
    Gonzalez Costas, S.
    GonzAlez-PiNeiro, A.
    Blanco-Prieto, S.
    Paez de La Cadena, M.
    Arias Santos, I.
    Leboreiro Enriquez, B.
    Bernardez Ferran, B.
    Brozos, E.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 92 - 92
  • [10] Erlotinib customization based on epidermal growth factor receptor (EGFR) mutations in stage IV non-small-cell lung cancer (NSCLC) patients (p)
    Porta, R.
    Queralt, C.
    Cardenal, F.
    Mayo, C.
    Provencio, M.
    Camps, C.
    Isla, D.
    Gonzalez-Larriba, J.
    Taron, M.
    Rosell, R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345